BioCentury This Week
BioCentury
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Episodes
Mentioned books
Jun 2, 2021 • 15min
Ep. 60 - D-Day for Aducanumab: What's at stake
Reach us by sending a text
Jun 2, 2021 • 24min
Ep. 59 - KRAS to the Future; plus ARPA-H & EGFR
Reach us by sending a text
May 24, 2021 • 25min
Ep. 58 - LAG3 Before You Leap; plus BEE21, G20 Highlights
Reach us by sending a text
May 10, 2021 • 28min
Ep. 57 - Financing Scandinavia; plus IP Waivers, Long Covid & AAV Pays
Reach us by sending a text
May 4, 2021 • 21min
Ep. 56 - FDA’s ODAC Bind; plus NK Cell Engagers and Company Creation in Europe
Reach us by sending a text
Apr 27, 2021 • 19min
Ep. 55 - German Plays Deliver on Data, plus Accelerated Approval on Trial
Reach us by sending a text
Apr 20, 2021 • 26min
Ep. 54 - Patient Groups’ Pandemic Pain; plus Voters’ Rights and Synthetic Lethality
Reach us by sending a text
Apr 13, 2021 • 24min
Ep. 53 - Competence & Continuity at CDER; plus BIO 3.0, AACR and 2Q Preview
Reach us by sending a text
Apr 6, 2021 • 24min
Ep. 52 - Memories of John Martin, plus AACR's Hot Targets & Bio€quity Europe Preview
Reach us by sending a text
Mar 30, 2021 • 18min
Ep. 51 - Abernethy & the Obvious at FDA; Plus CEPI & EpimAb
Reach us by sending a text
